Multicentric EORTC retrospective study shows efficacy of Brentuximab Vedotin in &#x39C;ycosis Fungoides and Sezary Syndrome patients with variable CD30 positivity

Dermatological manifestations in cardiofaciocutaneous syndrome: A prospective multicentric study of 45 mutation-positive patients

Br J Dermatol.

Bessis D, Morice-Picard F, Bourrat E, Abadie C, Aouinti S, Baumann C, Best M1, Bursztejn AC, Capri Y, Chiaverini C, Coubes C, Giuliano F, Hadj-Rabia S, Jacquemont ML, Lacombe D, Lyonnet S, Mallet S, Mazereeuw-Hautier J, Miquel J, Molinari N, Parfait B, Pernet C, Philip N, Pinson L, Pouvreau N, Vial Y, Sarda P, Sigaudy S, Verloes A, Cavé H, Geneviève D

doi: 10.1111/bjd.17077.

Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study

J Am Acad Dermatol.

Mangold AR, Thompson AK, Davis MD, Saulite I, Cozzio A, Guenova E, Hodak E, Amitay-Laish I, Pujol RM, Pittelkow MR, Gniadecki R

doi: 10.1016/j.jaad.2017.05.036.

Atopic Dermatitis

Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000-2015: a retrospective multicentre study

J Eur Acad Dermatol Venereol.

Dickel H, Kuhlmann L, Bauer A, Bircher AJ, Breuer K, Fuchs T, Grabbe J, Mahler V, Pföhler C, Przybilla B, Rieker-Schwienbacher J, Schröder-Kraft C, Simon D, Treudler R, Weisshaar E, Worm M, Trinder E, Geier J

doi: 10.1111/jdv.16250.

Psoriasis

Prospective, Observational, Non-Interventional, Multicentre Study on the Efficacy and Tolerability of a New Calcipotriol/Betamethasone Aerosol Foam (Enstilar^®) in Patients with Plaque Psoriasis under Daily Practice Conditions

Dermatology.

Gerdes S, Krakor M, Anger T, Hutt HJ, Körber A

doi: 10.1159/000486700.

Further Publications Dermatology

Disease characteristics, prognosis, and response to therapy in patients with large-cell transformed mycosis fungoides: a single-center retrospective study

J Am Acad Dermatol

O'Donnell M, Zaya R, Correia E, Krishnasamy S, Sahu J, Shi W, Cha J, Alpdogan SO, Porcu P, Nikbakht N

doi: 10.1016/j.jaad.2021.07.013

Autoimmune Disease

Clinical and immunological features of antiphospholipid syndrome in the elderly: a retrospective national multicentre study

Rheumatology (Oxford).

Grimaud F, Yelnik C, Pineton de Chambrun M, Amoura Z, Arnaud L, Costedoat Chalumeau N, Hachulla E, Lambert M, Roriz M, Sibilia J, Papo T, Sacre K

doi: 10.1093/rheumatology/key437.

Autoimmune Disease

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Lancet.

van Vollenhoven RF, Hahn BH, Tsokos GC, Wagner CL, Lipsky P, Touma Z, Werth VP, Gordon RM, Zhou B, Hsu B, Chevrier M, Triebel M, Jordan JL, Rose S

doi: 10.1016/S0140-

Melanoma and Skin Cancer

Brentuximab a novel antibody therapy: Real-World Use Confirms Efficacy and Tolerability for CD30 positive cutaneous lymphoma

Br J Dermatol.

Engelina S, Saggu M, Yoo J, Shah F, Stevens A, Irwin C, Chaganti S, Scarisbrick JJ

doi: 10.1111/bjd.18535.

Psoriasis

Tildrakizumab efficacy, drug survival, and safety are comparable in patients with psoriasis with and without metabolic syndrome: Long-term results from two phase 3 randomized controlled studies (reSURFACE 1 and reSURFACE 2)

J Am Acad Dermatol.

Lebwohl MG, Leonardi CL, Mehta NN, Gottlieb AB, Mendelsohn AM, Parno J, Rozzo SJ, Menter MA

doi: 10.1016/j.jaad.2020.09.047.

Dermatology · Immunology · Rheumatology

Multicentric EORTC retrospective study shows efficacy of Brentuximab Vedotin in Μycosis Fungoides and Sezary Syndrome patients with variable CD30 positivity

Related content